Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors

Madhavika N. Serasinghe, Shira Y. Wieder, Thibaud T. Renault, Rana Elkholi, James J. Asciolla, Jonathon L. Yao, Omar Jabado, Kyle Hoehn, Yusuke Kageyama, Hiromi Sesaki, Jerry E. Chipuk

Research output: Contribution to journalArticlepeer-review

285 Scopus citations


Mitochondrial division is essential for mitosis and metazoan development, but a mechanistic role in cancer biology remains unknown. Here, we examine the direct effects of oncogenic RASG12V-mediated cellular transformation on the mitochondrial dynamics machinery and observe a positive selection for dynamin-related protein 1 (DRP1), a protein required for mitochondrial network division. Loss ofDRP1 prevents RASG12V-induced mitochondrial dysfunction and renders cells resistant to transformation. Conversely, in human tumor cell lines with activating MAPK mutations, inhibition of these signals leads to robust mitochondrial network reprogramming initiated by DRP1 loss resulting in mitochondrial hyper-fusion and increased mitochondrial metabolism. These phenotypes are mechanistically linked by ERK1/2 phosphorylation of DRP1 serine 616; DRP1S616 phosphorylation is sufficient to phenocopy transformation-induced mitochondrial dysfunction, and DRP1S616 phosphorylation status dichotomizes BRAFWT from BRAFV600E-positive lesions. These findings implicate mitochondrial division and DRP1 as crucial regulators of transformation with leverage in chemotherapeutic success.

Original languageEnglish
Pages (from-to)521-536
Number of pages16
JournalMolecular Cell
Issue number3
StatePublished - 5 Feb 2015


Dive into the research topics of 'Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors'. Together they form a unique fingerprint.

Cite this